| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acid-base abnormalities and liver dysfunction
|
Katopodis, Periklis
|
|
|
27 |
2 |
p.
|
artikel
|
| 2 |
Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways
|
Vargas-Pozada, Eduardo E.
|
|
|
27 |
2 |
p.
|
artikel
|
| 3 |
Circ-LARP1B knockdown restrains the tumorigenicity and enhances radiosensitivity by regulating miR-578/IGF1R axis in hepatocellular carcinoma
|
Zhu, Shuangmei
|
|
|
27 |
2 |
p.
|
artikel
|
| 4 |
Economic evaluation of long-term albumin use in cirrhosis patients from the Mexican healthcare system perspective
|
Moctezuma-Velazquez, Carlos
|
|
|
27 |
2 |
p.
|
artikel
|
| 5 |
EDITORIAL BOARD
|
|
|
|
27 |
2 |
p.
|
artikel
|
| 6 |
Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis
|
Shu, Wu
|
|
|
27 |
2 |
p.
|
artikel
|
| 7 |
Introduction of a standardized protocol for cardiac risk assessment in candidates for liver transplant – A retrospective cohort analysis
|
McCarthy, Killian J.
|
|
|
27 |
2 |
p.
|
artikel
|
| 8 |
Laparoscopic cholecystectomy: Histopathological analysis of metabolic associated fatty liver disease and fibrosis
|
Rodríguez-Antonio, Itzayana
|
|
|
27 |
2 |
p.
|
artikel
|
| 9 |
Liver transplant outcomes during the COVID-19 pandemic
|
Mendizabal, Manuel
|
|
|
27 |
2 |
p.
|
artikel
|
| 10 |
Long-term prediction of hepatocellular carcinoma using serum autotaxin levels after antiviral therapy for hepatitis C
|
Ando, Wataru
|
|
|
27 |
2 |
p.
|
artikel
|
| 11 |
Nomogram for prediction of long-term survival with hepatocellular carcinoma based on NK cell counts
|
Yu, Lihua
|
|
|
27 |
2 |
p.
|
artikel
|
| 12 |
Prevalence of fatty liver disease after liver transplantation and risk factors for recipients and donors
|
Horiuchi, Kentaro
|
|
|
27 |
2 |
p.
|
artikel
|
| 13 |
Prevalence of non alcoholic fatty liver disease and associated factors?
|
Moran, Segundo
|
|
|
27 |
2 |
p.
|
artikel
|
| 14 |
Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing
|
Yang, Fan
|
|
|
27 |
2 |
p.
|
artikel
|
| 15 |
Reply to: “correspondence about “Efficacy and safety of basiliximab”
|
Hashim, Mohamed
|
|
|
27 |
2 |
p.
|
artikel
|
| 16 |
Reply to letter to the editor
|
Denova-Gutiérrez, Edgar
|
|
|
27 |
2 |
p.
|
artikel
|
| 17 |
Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway
|
Jin, Si-Si
|
|
|
27 |
2 |
p.
|
artikel
|
| 18 |
The role of basiliximab in renal function after liver transplantation
|
Gastaca, Mikel
|
|
|
27 |
2 |
p.
|
artikel
|
| 19 |
Training in Hepatology: From medical school to a Ph.D. and clinical specialty program
|
Panduro, Arturo
|
|
|
27 |
2 |
p.
|
artikel
|
| 20 |
Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit
|
Chen, Zhangbin
|
|
|
27 |
2 |
p.
|
artikel
|
Tijdschrift beschrijving